new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Boehringer Ingelheim International Gmbh
Boehringer Ingelheim International Gmbh x26 Co Kg
Boehringer Ingelheim International Gmbh Vitae Pharmaceuticals
Boehringer Ingelheim International Gmbh_20100107
Boehringer Ingelheim International Gmbh_20100121
Boehringer Ingelheim International Gmbh_20131212
Boehringer Ingelheim International Gmbh_20100128
Boehringer Ingelheim International Gmbh_20100114
  

Boehringer Ingelheim International Gmbh patents

Recent patent applications related to Boehringer Ingelheim International Gmbh. Boehringer Ingelheim International Gmbh is listed as an Agent/Assignee. Note: Boehringer Ingelheim International Gmbh may have other listings under different names/spellings. We're not affiliated with Boehringer Ingelheim International Gmbh, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Boehringer Ingelheim International Gmbh-related inventors




Date Boehringer Ingelheim International Gmbh patents (updated weekly) - BOOKMARK this page
05/11/17System with nebulizer and container
05/11/17Nebulizer and container
05/11/17Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
05/04/17Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
04/27/17Quinazoline derivatives for the treatment of cancer diseases
04/20/17Methods of treating diseases
04/20/17Ang2-binding molecules
04/13/17Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide
04/06/17Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets
04/06/17Pharmaceutical composition and uses thereof
03/30/17Uses of dpp iv inhibitors
03/30/17Anticancer combination therapy
03/30/17Cd33 binding agents
03/23/17Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
03/23/178-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
03/23/17Methods of treating inflammatory diseases
03/16/17Fast dissolving granulate
03/16/17Nebulizer
03/16/17Nebulizer and container
03/16/17Nebulizer
03/16/17New pyrazolyl-substituted heteroaryls and their use as medicaments
03/16/17Novel substituted spirocycles
03/09/17Pharmaceutical dosage form for immediate release of an indolinone derivative
03/09/17Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
03/09/17Cardio- and renoprotective antidiabetic therapy
03/02/17Use of anti-cd40 antibodies for treatment of lupus nephritis
03/02/17Anti-cd40 antibodies
02/23/17Combination therapy for treating hcv infection
02/23/17Container, indicator device, and nebulizer
02/23/17Novel annelated benzamides
02/23/17Novel annelated phenoxyacetamides
02/09/17Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
02/09/17Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product
02/02/17Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
01/26/176-alkynyl-pyridine derivatives
01/26/17Treatment for diabetes in patients inappropriate for metformin therapy
01/26/17Pharmaceutical composition, methods for treating and uses thereof
01/26/17Polymorphs
01/26/17Compound targeting il-23a and b-cell activating factor (baff) and uses thereof
01/12/17Compounds as modulators of ror gamma
01/12/17Heteroaryl syk inhibitors
01/12/17Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
01/05/17Multi-specific binding proteins
12/22/16Olefin substituted oxindoles having ampk activity
12/15/16New compounds
12/08/16Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
12/08/16Cx3cr1-binding polypeptides
12/01/16Glucagon analogues
12/01/16Artificial introns
11/24/16Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
11/24/16Pyrazole compounds as btk inhibitors
11/17/16Anti-il-23 antibodies
11/10/16Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
10/27/16Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
10/20/16Method for treatment of solid malignancies including advanced or metastatic solid malignancies
10/20/16Methods of treating diseases
10/13/16Novel process for the manufacture of 4-aminobenzoamidine dihydrochloride
10/06/16Methods of administering an egfr inhibitor
09/22/16Inhibitors of beta-secretase
09/22/16Amylin analogues
09/15/16Stable powder formulation containing an anticholingeric agent
09/01/16Pharmaceutical combination
08/25/16Method for treating acute myeloid leukemia
08/25/16Substituted 3-haloallylamine inhibitors of ssao and uses thereof
08/25/16Heteroaryl syk inhibitors
Patent Packs
08/18/16Pharmaceutical compositions
08/18/16Indanyloxydihydrobenzofuranylacetic acids
08/04/16Methods of treating inflammatory diseases
08/04/16Anti-cd40 antibodies
07/21/16Purin derivatives for use in the treatment of fab-related diseases
07/21/16Hcv combination therapy
07/14/165-alkynyl-pyrimidines
07/14/16Combination therapy for neoplasia treatment
07/14/16Vegf-binding molecules
07/07/16Lozenge for treating sore throat, hoarseness and associated dry cough, and inflammatory diseases of the oral and pharyngeal cavity
07/07/16Inhaler
07/07/168-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
06/23/16Binding molecules for bcma and cd3
06/09/16Pharmaceutical composition, methods for treating and uses thereof
06/09/16N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
Patent Packs
05/26/16Efficacious treatment of nsclc and predictive clinical marker of the responsiveness of a tumour to a treatment
05/26/16Filter system for use in medical devices
05/19/16Medicaments for the treatment or prevention of fibrotic diseases
05/19/16Purin derivatives for use in the treatment of fab-related diseases
05/19/16Anti cd37 antibodies
05/12/16Substituted [1,2,4]triazolo[4,3-a]pyrazines as brd4 inhibitors
05/12/16Spiro-substituted oxindole derivatives having ampk activity
05/12/16Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
05/12/16Bcma-based stratification and therapy for multiple myeloma patients
05/05/16Polymorphs
04/21/16Novel propellant containing preparations for tiotropium
04/21/16Pharmaceutical composition and uses thereof
04/21/16Combination of cd37 antibodies with chlorambucil
04/21/16Aldosterone synthase inhibitors
04/14/16Method for egfr directed combination treatment of cancer
04/14/16Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
04/07/16Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
04/07/16Adapter, inhalation device, and atomizer
03/31/16Cardio- and renoprotective antidiabetic therapy
03/24/16Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
03/24/16Use of ccr3-inhibitors
03/24/16Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
03/17/16Beta2-adrenoceptor agonist for the treatment of cough
03/17/16Methods of treatment and pharmaceutical compositions using an sglt-2 inhibitor and a neuroleptic agent
03/17/16Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereof
03/17/16Novel substituted spirocycles
03/17/16Compounds as modulators of ror gamma
03/10/16Pharmaceutical combinations for the treatment of metabolic disorders
03/03/16Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
03/03/16Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
Social Network Patent Pack
03/03/16Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
03/03/16Compound targeting il-23a and tnf-alpha and uses thereof
02/25/16Spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors
02/18/16Pharmaceutical formulation
02/11/16Combination therapy
02/11/16Pharmaceutical compositions comprising bi-1356 and metformin
02/11/16Pharmaceutical composition, methods for treating and uses thereof
02/11/16Pharmaceutical composition, methods for treating and uses thereof
02/11/16Pharmaceutical composition, methods for treating and uses thereof
02/11/16Method for producing dabigatran etexilate methansulphonate
Patent Packs
02/11/16Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
02/11/166-alkynyl-pyridine derivatives
02/11/16Azabenzimidazole derivatives
02/04/16Oral disintegrating tablet
02/04/16Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
02/04/16Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
02/04/16Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
02/04/16Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
02/04/16Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
02/04/16Substituted oxetanes and their use as inhibitors of cathepsin c
02/04/16Heteroaromatic compounds as btk inhibitors
01/28/16Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
01/28/16Dpp iv inhibitor formulations
01/28/16Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
01/28/16Aldosterone synthase inhibitors
01/21/16Use of a dpp-4 inhibitor in autoimmune diabetes, particularly lada
01/21/16Protein purification by means of aqueous two-phase centrifugal extraction
01/07/16New spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors
01/07/16Pharmaceutical composition, methods for treating and uses thereof
12/31/15Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
12/31/15New compounds
12/24/15Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
12/24/15Radiolabeled quinazoline derivatives
12/17/15Sulfoximine substituted quinazolines for pharmaceutical compositions
11/26/15Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
11/12/15Nebulizer
11/12/15Container, nebulizer and use
11/12/15Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
11/12/15Benzimidazole derivatives
11/05/15Inhibitors of cytomegalovirus
Patent Packs
11/05/15Anti-cd40 antibodies
10/29/15Propellant-free aerosol formulation for inhalation
10/15/15Hepatitis c inhibitor compounds
10/15/15Compounds as modulators of ror gamma
10/15/15New spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors
10/15/158-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
10/08/15Inhibitors of cytomegalovirus
10/08/15Inhalation training device and system for practicing of an inhalation process of a patient
10/08/15Method, electronic device, inhalation training system and information storage medium for practicing and/or controlling an inhalation process of a patient
10/08/15Cd33 binding agents
10/01/15Quinazoline derivatives for the treatment of cancer diseases
09/24/15Use of moisture-conditioned disintegrants or expanding agents in tablet manufacture for the selective adjustment of the mechanical properties, the dissolving kinetics and/or the water loading of the tablets
09/24/15Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis
09/24/15Superior efficacy of cd37 antibodies in cll blood samples
09/17/15Inhalant propellant-free aerosol formulation
09/17/15Novel propellant containing preparations for tiotropium
09/17/15Novel powdered crystalline medicines for inhalation
09/10/15New substituted glycinamides, process for their manufacture and use thereof as medicaments
09/03/15Medical use of a dpp-4 inhibitor
09/03/15Pyridinones
Social Network Patent Pack
08/27/15Inhibitors of beta-secretase
08/27/15Substituted pyridones and pyrazinones and their use as inhibitors of neutrophil elastase activity
08/27/15Cx3cr1-binding polypeptides
08/27/15Lyophilised dabigatran
08/20/15Combination of cd37 antibodies with bendamustine
08/20/15Fused thiazin-3-ones as kca3.1 inhibitors
08/13/15Use of tiotropium salts in the treatment of moderate persistent asthma
08/13/15N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof
08/06/15Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
08/06/15Novel anti-baff antibodies
07/30/15Treatment of cancer
07/30/15Anticoagulant antidotes
07/23/15Anti il-36r antibodies
07/16/15Vasoprotective and cardioprotective antidiabetic therapy
07/09/15Stabilized pharmaceutical formulations of a potent hcv inhibitor
07/02/15Process for the manufacture of (e)-4-n,n-dialkylamino crotonic acid in hx salt form and use thereof for synthesis of egfr tyrosine kinase inhibitors
06/25/15Pharmaceutical combination
06/18/15Hcv combination therapy
06/18/15Combination therapy for treating hcv infection in an hcv-hiv coinfected patient population
06/18/15Closure system for an applicator attachment on a container for pharmaceutical preparations, and use, container with closure system, syringe for medical purposes, and assembly
Social Network Patent Pack
06/18/15Crystalline salts of a potent hcv inhibitor
06/11/15Cytomegalovirus inhibitor compounds
06/04/15Inhibitors of beta-secretase
06/04/15Pharmaceutical formulation for a therapeutic antibody
05/28/15Combination therapy for treating hcv infection in specific patient subgenotype sub-population
05/28/15Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
05/28/15Indanyloxyphenylcyclopropanecarboxylic acids
05/21/15Cell engineering using rnas
05/21/15Hexahydroindenopyridine derivatives
05/14/15Triazolopyrazine
05/07/15Nebuliser with coding means
05/07/15Pharmaceutical combinations comprising cd33 antibodies and de-methylating agents
05/07/15Substituted naphthyridines and their use as medicaments
04/30/15Nebulizer
04/30/15Anticoagulant antidotes
04/30/15New azabenzimidazole derivatives
04/30/15Methods for making oxetan-3-ylmethanamines
04/23/15Glucagon analogues
04/23/15Acylated glucagon analogues
04/23/15Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
04/16/15Antidiabetic medications
04/16/15Co-crystals and salts of ccr3-inhibitors
04/16/15Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
04/16/15Piperazine derivatives and the use thereof as medicament
04/09/15Use of ccr3-inhibitors
03/26/15Process and intermediates for preparing gpr40 agonists
03/19/15Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
03/19/15Cytomegalovirus inhibitor compounds
03/05/15Substituted quinolines and their use as medicaments
02/26/15New bis-amido pyridines
Social Network Patent Pack
02/26/15New 6-alkynyl pyridine
02/19/15Pyridinones
02/12/15Nebulizer
02/12/15Nebulizer
02/12/15Nebulizer
02/12/15Novel pyrazine amide compounds
02/12/15Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
02/05/15Pharmaceutical composition of a potent hcv inhibitor for oral administration
02/05/15Process for preparing carboxylic acids
01/29/15Combination treatment of acute myeloid leukemia and myelodysplastic syndrome i
01/29/15Combination treatment of acute myeloid leukemia and myelodysplastic syndrome ii
01/29/15Treatment of myelodysplastic syndrome
01/22/15Binding molecules for bcma and cd3
01/22/15New azabenzimidazole derivatives
01/22/156-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders
01/22/15Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
01/15/15Method for the evaluation of the colloidal stability of liquid biopolymer solutions
01/15/15Novel 5-substituted benzimidazolium compounds
01/15/15Novel benzimidazolium compounds
01/15/15Novel tetra- and pentasubstituted benzimidazolium compounds
01/15/15Inhibitors of leukotriene production
01/15/15Inhibitors of leukotriene production
01/15/15Novel chiral nitrogen-phosphorus ligands and their use for asymmetric hydrogenation of alkenes
01/08/15Anti-igf antibodies
01/08/15Inhibitors of hiv replication
01/08/15Heterocyclic compounds, medicaments containing them, use and processes for the preparation thereof
01/01/15Sulfoximine substituted quinazolines for pharmaceutical compositions
01/01/15Administration of ethyl 3-[(2--1-methyl-1h-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionate
01/01/15Novel ruthenium catalysts and their use for asymmetric reduction of ketones







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Boehringer Ingelheim International Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Boehringer Ingelheim International Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';